A Systematic Dilution Study of Self-Microemulsifying Drug Delivery Systems in Artificial Intestinal Fluid Using Dynamic Laser Light Backscattering

REFERENCES

• M. Borkovec. (1989). From micelles to microemulsion droplets: Size distribution, shape fluctuations and interfacial tensions. J. Phys. Chem. 91 (10):6268–6291.
   Google Scholar
• M. Brogård, E. Troedsson, K. Thuresson, and H. Ljusberg-Wahren. (2007). A new standardized lipolysis approach for the characterization of emulsions and dispersions. J. Colloid. Interface Sci. 308:500–507.
   PubMed Web of Science ®Google Scholar
• S. Ciu, C. H. Zhao, D. Chen, and Z. He. (2005). Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of pueraria lobata isoflavoine. Drug Dev. Ind. Pharm. 31:349–356.
   PubMed Web of Science ®Google Scholar
• P. P. Constantinides, C. M. Lancaster, J. Marcello, D. C. Chiossone, D. Orner, I. Hidalgo, P. L. Smith, A. B. Sarkahian, S. H. Yiv, and A. J. Owen. (1995). Enhanced intestinal absorption of a RGD peptide from water-in-oil microemulsions of different composition and particle size. J. Control. Release 34:109–116.
   Web of Science ®Google Scholar
• P. Constantinides, and J. P. Scalart. (1997). Formulation and physical characterisation of water-in-oil microemulsions containing long-versus medium-chain glycerides. Int. J. Pharm. 158:57–68.
   Web of Science ®Google Scholar
• J. F. Cuiné, W. N. Charman, C. W. Pouton, G. A. Edwards, and C. H. Porter. (2007). Increasing the proportional content of surfactants (cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm. Res. 24 (4):748–757.
   PubMed Web of Science ®Google Scholar
• J. F. Cuiné, C. L. Mcevoy, W. N. Charman, C. W. Pouton, G. A. Edwards, H. Benameur, and C. H. Porter. (2008). Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J. Pharm. Sci. 97 (2):993–1010.
   Google Scholar
• A. Dahan, and A. Hoffman. (2005). Evaluation of chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur. J. Pharm. Sci. 24:381–388.
   PubMed Web of Science ®Google Scholar
• C. Ditner. (2007). Untersuchung des Verdünnungsverhaltens selbstemulgierender Systeme. Master Thesis, University of Basel, Institute of Pharmaceutical Technology.
   Google Scholar
• D. G. Fatouros, and A. Müllertz. (2008). In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin. Drug Metab. Toxicol 4 (1):65–76.
   Google Scholar
• E. Galia, E. Nicolaides, D. Hörter, R. Löbenberg, C. Reppas, and J. B. Dressman. (1998). Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 15 (5):698–705.
   PubMed Web of Science ®Google Scholar
• P. Gao, B. Rush, W. Pfund, T. Huang, J. Bauer, W. Morozowich, K. Ming-Shang, and M. Hageman. (2003). Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved Oral Bioavailability. J. Pharm. Sci. 92 (12):2386–2398.
   PubMed Web of Science ®Google Scholar
• R. Gursoy, and S. Benita. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58:173–182.
   PubMed Web of Science ®Google Scholar
• R. Holm, and I. H. M. Jensen. (2006). Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev. Ind. Pharm. 32:1025–1032.
   PubMed Web of Science ®Google Scholar
• J. Y. Hong, J. K. Kim, Y. K. Song, J. S. Park, and C. K. Kim. (2006). A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J. Control. Release 110:332–338.
   PubMed Web of Science ®Google Scholar
• K. Iwanaga, T. Kushibiki, M. Miyazaki, and M. Kakemi. (2006). Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble. Drugs Biol. Pharm. Bull. 29 (3):508–512.
   PubMed Web of Science ®Google Scholar
• S. B. Kapitza, B. Michel, P. van Hoogevest, M. Leigh, and G. Imanidis. (2007). Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the caco-2 cell model. Eur. J. Pharm. Biopharm. 66:146–158.
   PubMed Web of Science ®Google Scholar
• S. M. Khoo, A. J. Humberstone, C. H. Porter, G. Edwards, and W. Charman. (1998). Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 15:5–164.
   Google Scholar
• G. A. Kossena, W. Charman, B. J. Boyd, and C. H. Porter. (2005). Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. J. Pharm. Sci. 94 (3):481–492.
   PubMed Web of Science ®Google Scholar
• M. Kuentz, N. Wyttenbach, and O. Kuhlmann. (2007). Application of a statistical method to the absorption of a new model drug from micellar and lipid formulations- evaluation of qualitative excipient effects. Pharm. Dev. Technol. 12:275–283.
   PubMed Web of Science ®Google Scholar
• F. Nielsen, E. Gibault, H. Ljusberg-Wahren, L. Arleth, J. S. Pedersen, and A. Müllertz. (2007). Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J. Pharm. Sci. 96 (4):876–892.
   PubMed Web of Science ®Google Scholar
• C. O'Driscoll. (2002). Lipid-based formulations for the intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15:405–415.
   PubMed Web of Science ®Google Scholar
• C. Porter, and W. Charman. (2001). In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev. 50:S127–S147.
   PubMed Web of Science ®Google Scholar
• C. H. Porter, A. M. Kaukonen, A. Taillardat-Bertschinger, B. J. Boyd, J. M. O'Connor, G. A. Edwards, and W. Charman. (2004). Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Study with halofantrine. J. Pharm. Sci. 93 (5):1110–1121.
   PubMed Web of Science ®Google Scholar
• C. H. Porter, C. Pouton, J. Cuine, and W. Chaman. (2008). Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 60:673–691.
   PubMed Web of Science ®Google Scholar
• C. H. Porter, N. Trevaskis, and W. Charman. (2007). Lipid and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6 (3):231–248.
   PubMed Web of Science ®Google Scholar
• C. Pouton. (1997). Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 25:47–58.
   Web of Science ®Google Scholar
• C. W. Pouton. (2000). Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying, and self-microemulsifying drug delivery systems. Eur. J. Pharm. Sci. 11 (2):S93–S98.
   PubMed Web of Science ®Google Scholar
• C. W. Pouton. (2006). Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Europ J. Pharm. Sci. 29:278–287.
   PubMed Web of Science ®Google Scholar
• F. Seeballuk, E. Lawless, M. Ashford, and C. O'Discoll. (2003). The effect of pluronic® block copolymers and cremophor® EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in caco-2 cells. Pharm. Res. 20 (7):1085–1092.
   PubMed Web of Science ®Google Scholar
• F. Seeballuk, E. Lawless, M. Ashford, and C. O'Discoll. (2004). Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: In vitro and in vivo correlation using caco-2 cells and a cannulated rat intestinal lymphatic model. Pharm. Res. 21 (12):2320–2326.
   PubMed Web of Science ®Google Scholar
• L. Sek, C. Porter, A. M. Kaukonen, and W. Charman. (2002). Evaluation of the in-vitro digestion profiles for long and medium chain triglycerides and the phase behaviour of the lipolytic products. J. Pharm. Pharmacol. 54:29–41.
   PubMed Web of Science ®Google Scholar
• H. R. Shen, and M. K. Zhong. (2006). Preparation and evaluation of self-emulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol. 58:1183–1191.
   PubMed Web of Science ®Google Scholar
• R. J. Stokes, and D. F. Evans. (1997). Can we quantitatively model micelle formation and stability in fundamentals of interfacial engineering ( pp. 219–222). Chichester: Wiley New York.
   Google Scholar
• T. Takagi, C. H. Ramachandran, M. Bermejo, S. Yamashita, L. Yu, and G. Amidon. (2006). A provisional biopharmaceutical classification of top 200 oral drug products in the United States, Great Britain, Spain and Japan. Mol. Pharm. 3 (6):631–643.
   PubMedGoogle Scholar
• M. Vertzoni, N. Fotaki, E. Kostewicz, E. Stippler, C. H. Leuner, E. Nicolaides, J. Dressman, and C. H. Reppas. (2004). Dissolution media simulating the intralumenal composition of the small intestine: Physiological issues and practical aspects. J. Pharm. Pharmacol. 56:453–462.
   PubMed Web of Science ®Google Scholar